Literature DB >> 10561527

Motor cortex inhibition is not impaired in patients with Alzheimer's disease: evidence from paired transcranial magnetic stimulation.

J L Pepin1, D Bogacz, V de Pasqua, P J Delwaide.   

Abstract

Motor cortex excitability was studied by transcranial magnetic stimulation (TMS) in 17 patients with Alzheimer's disease (AD). Resting and active thresholds for TMS were significantly reduced in AD patients compared to young and aged healthy subjects. The maximum amplitude of the motor response evoked by TMS was also significantly increased in AD patients. We have tested if these changes are related to a modification of the short-lasting intracortical inhibition of the motor cortex by paired conditioning-test TMS. We found no significant differences between AD patients and aged healthy subjects even if there is a slight but significant difference between aged and young normal subjects. We conclude that the modification of excitability of the motor cortex does not result from an impaired intracortical inhibition.

Entities:  

Mesh:

Year:  1999        PMID: 10561527     DOI: 10.1016/s0022-510x(99)00206-3

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  16 in total

Review 1.  Noninvasive brain stimulation in Alzheimer's disease: systematic review and perspectives for the future.

Authors:  Catarina Freitas; Helena Mondragón-Llorca; Alvaro Pascual-Leone
Journal:  Exp Gerontol       Date:  2011-04-14       Impact factor: 4.032

2.  Reduced interhemispheric inhibition in mild cognitive impairment.

Authors:  Ryosuke Tsutsumi; Ritsuko Hanajima; Masashi Hamada; Yuichiro Shirota; Hideyuki Matsumoto; Yasuo Terao; Shinya Ohminami; Yoshihiro Yamakawa; Hiroyuki Shimada; Shoji Tsuji; Yoshikazu Ugawa
Journal:  Exp Brain Res       Date:  2012-01-11       Impact factor: 1.972

3.  L-dopa modulates motor cortex excitability in Alzheimer's disease patients.

Authors:  Alessandro Martorana; Alessandro Stefani; Maria Giuseppina Palmieri; Zaira Esposito; Giorgio Bernardi; Giuseppe Sancesario; Mariangela Pierantozzi
Journal:  J Neural Transm (Vienna)       Date:  2008-07-02       Impact factor: 3.575

Review 4.  Cortical excitability and neurology: insights into the pathophysiology.

Authors:  Radwa A B Badawy; Tobias Loetscher; Richard A L Macdonell; Amy Brodtmann
Journal:  Funct Neurol       Date:  2012 Jul-Sep

Review 5.  Transcranial magnetic stimulation in Alzheimer's disease: a neurophysiological marker of cortical hyperexcitability.

Authors:  Giovanni Pennisi; Raffaele Ferri; Giuseppe Lanza; Mariagiovanna Cantone; Manuela Pennisi; Valentina Puglisi; Giulia Malaguarnera; Rita Bella
Journal:  J Neural Transm (Vienna)       Date:  2011-01-05       Impact factor: 3.575

6.  Cortical excitability in very mild Alzheimer's disease: a long-term follow-up study.

Authors:  J Olazarán; J Prieto; I Cruz; A Esteban
Journal:  J Neurol       Date:  2010-07-31       Impact factor: 4.849

Review 7.  Transcranial magnetic stimulation for the treatment of depression in neurologic disorders.

Authors:  Felipe Fregni; Alvaro Pascual-Leone
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

8.  Dopamine differently modulates central cholinergic circuits in patients with Alzheimer disease and CADASIL.

Authors:  Raffaele Nardone; Yvonne Höller; Aljosha Thomschewski; Alexander Baden Kunz; Piergiorgio Lochner; Stefan Golaszewski; Eugen Trinka; Francesco Brigo
Journal:  J Neural Transm (Vienna)       Date:  2014-03-28       Impact factor: 3.575

9.  Intra- and inter-cortical motor excitability in Alzheimer's disease.

Authors:  Jacqueline Hoeppner; Martin Wegrzyn; Johannes Thome; Alexandra Bauer; Imke Oltmann; Johannes Buchmann; Stefan Teipel
Journal:  J Neural Transm (Vienna)       Date:  2011-11-13       Impact factor: 3.575

10.  Higher motor cortical excitability linked to greater cognitive dysfunction in Alzheimer's disease: results from two independent cohorts.

Authors:  Siddhesh Zadey; Stephanie S Buss; Katherine McDonald; Daniel Z Press; Alvaro Pascual-Leone; Peter J Fried
Journal:  Neurobiol Aging       Date:  2021-06-24       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.